Literature DB >> 27929735

Development of adsorptive hybrid filters to enable two-step purification of biologics.

Nripen Singh1, Abhiram Arunkumar1, Michael Peck1, Alexei M Voloshin2, Angela M Moreno2, Zhijun Tan1, Jonathan Hester2, Michael C Borys1, Zheng Jian Li1.   

Abstract

Recent progress in mammalian cell culture process has resulted in significantly increased product titers, but also a substantial increase in process- and product-related impurities. Due to the diverse physicochemical properties of these impurities, there is constant need for new technologies that offer higher productivity and improved economics without sacrificing the process robustness required to meet final drug substance specifications. Here, we examined the use of new synthetic adsorptive hybrid filters (AHF) modified with the high binding capacity of quaternary amine (Emphaze™ AEX) and salt-tolerant biomimetic (Emphaze™ ST-AEX) ligands for clearance of process-related impurities like host cell protein (HCP), residual DNA, and virus. The potential to remove soluble aggregates was also examined. Our aim was to develop a mechanistic understanding of the interactions governing adsorptive removal of impurities during filtration by evaluating the effect of various filter types, feed streams, and process conditions on impurity removal. The ionic capacity of these filters was measured and correlated with their ability to remove impurities for multiple molecules. The ionic capacity of AHF significantly exceeded that of traditional adsorptive depth filters (ADF) by 40% for the Emphaze™ AEX and by 700% for the Emphaze™ ST-AEX, providing substantially higher reduction of soluble anionic impurities, including DNA, HCPs and model virus. Nevertheless, we determined that ADF with filter aid provided additional hydrophobic functionality that resulted in removal of higher molecular weight species than AHF. Implementing AHF demonstrated improved process-related impurity removal and viral clearance after Protein A chromatography and enabled a two-step purification process. The consequences of enhanced process performance are far reaching because it allows the downstream polishing train to be restructured and simplified, and chromatographic purity standards to be met with a reduced number of chromatographic steps.

Entities:  

Keywords:  Adsorptive filters; clarification; hybrid filters; process compression; purification; viral clearance

Mesh:

Substances:

Year:  2016        PMID: 27929735      PMCID: PMC5297532          DOI: 10.1080/19420862.2016.1267091

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  42 in total

1.  Host cell protein dynamics in the supernatant of a mAb producing CHO cell line.

Authors:  A S Tait; C E M Hogwood; C M Smales; D G Bracewell
Journal:  Biotechnol Bioeng       Date:  2011-12-12       Impact factor: 4.530

2.  Studying host cell protein interactions with monoclonal antibodies using high throughput protein A chromatography.

Authors:  Vikram N Sisodiya; Joshua Lequieu; Maricel Rodriguez; Paul McDonald; Kathlyn P Lazzareschi
Journal:  Biotechnol J       Date:  2012-06-22       Impact factor: 4.677

3.  Host cell protein adsorption characteristics during protein A chromatography.

Authors:  Richard D R Tarrant; M Lourdes Velez-Suberbie; Andrew S Tait; C Mark Smales; Daniel G Bracewell
Journal:  Biotechnol Prog       Date:  2012-07-20

4.  Viral clearance using disposable systems in monoclonal antibody commercial downstream processing.

Authors:  Joe X Zhou; Felix Solamo; Tony Hong; Michael Shearer; Tim Tressel
Journal:  Biotechnol Bioeng       Date:  2008-06-15       Impact factor: 4.530

Review 5.  Upstream processes in antibody production: evaluation of critical parameters.

Authors:  Era Jain; Ashok Kumar
Journal:  Biotechnol Adv       Date:  2007-09-19       Impact factor: 14.227

6.  Exploration of overloaded cation exchange chromatography for monoclonal antibody purification.

Authors:  Hui F Liu; Beth McCooey; Tiago Duarte; Deanna E Myers; Terry Hudson; Ashraf Amanullah; Robert van Reis; Brian D Kelley
Journal:  J Chromatogr A       Date:  2011-08-12       Impact factor: 4.759

7.  Host cell protein dynamics in recombinant CHO cells: impacts from harvest to purification and beyond.

Authors:  Catherine Em Hogwood; Daniel G Bracewell; C Mark Smales
Journal:  Bioengineered       Date:  2013-01-17       Impact factor: 3.269

8.  Avoiding antibody aggregation during processing: establishing hold times.

Authors:  Varsha Joshi; Tarun Shivach; Vijesh Kumar; Nitin Yadav; Anurag Rathore
Journal:  Biotechnol J       Date:  2014-05-12       Impact factor: 4.677

Review 9.  Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives.

Authors:  Nripen Singh; Abhiram Arunkumar; Srinivas Chollangi; Zhijun George Tan; Michael Borys; Zheng Jian Li
Journal:  Biotechnol Bioeng       Date:  2015-09-29       Impact factor: 4.530

Review 10.  Recent advances in technology supporting biopharmaceutical production from mammalian cells.

Authors:  M Butler; A Meneses-Acosta
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-05       Impact factor: 4.813

View more
  3 in total

1.  Analysis of fouling and breakthrough of process related impurities during depth filtration using confocal microscopy.

Authors:  Maria Parau; Thomas F Johnson; James Pullen; Daniel G Bracewell
Journal:  Biotechnol Prog       Date:  2022-01-26

2.  Chromatographic capture of cells to achieve single stage clarification in recombinant protein purification.

Authors:  Aaron Almeida; David Chau; Thomas Coolidge; Hani El-Sabbahy; Steven Hager; Kevin Jose; Masa Nakamura; Alexei Voloshin
Journal:  Biotechnol Prog       Date:  2021-12-08

3.  The uniqueness of flow in probing the aggregation behavior of clinically relevant antibodies.

Authors:  Leon F Willis; Amit Kumar; Tushar Jain; Isabelle Caffry; Yingda Xu; Sheena E Radford; Nikil Kapur; Maximiliano Vásquez; David J Brockwell
Journal:  Eng Rep       Date:  2020-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.